New hope for kids with deadly brainstem glioma? early safety trial completed.
NCT ID NCT01165333
First seen Mar 22, 2026 · Last updated May 10, 2026 · Updated 10 times
Summary
This early-phase study tested the safety of a drug called cilengitide when given together with radiation therapy for children and young adults with a rare, aggressive brain tumor called diffuse intrinsic pontine glioma (DIPG). The main goal was to find the highest safe dose of cilengitide. 32 participants took part, and the study focused on tracking side effects and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE INTRINSIC PONTINE GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU
Toulouse, 33059, France
-
CHU, Hôpital d'Enfants de la Timone
Marseille, 13385, France
-
Centre Hospitalier Universitaire de Nantes
Nantes, 44093, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Hôpital des Enfants, Groupe Hospitalier
Bordeaux, 33076, France
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
-
Institut Curie
Paris, 75231, France
-
Institut Gustave-Roussy
Villejuif, 94805, France
Conditions
Explore the condition pages connected to this study.